Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 228 of 239
Eightco Holdings Inc.
Shares:506
Value:$541
% of Portfolio:0.0% ($541/$44.8B)
abrdn Gold ETF Trust
Shares:18
Value:$537
% of Portfolio:0.0% ($537/$44.8B)
OPPENHEIMER HOLDINGS INC
Shares:9
Value:$537
% of Portfolio:0.0% ($537/$44.8B)
TScan Therapeutics, Inc.
Shares:386
Value:$533
% of Portfolio:0.0% ($533/$44.8B)
Southland Holdings, Inc.
Shares:176
Value:$526
% of Portfolio:0.0% ($526/$44.8B)
Telomir Pharmaceuticals, Inc.
Shares:163
Value:$526
% of Portfolio:0.0% ($526/$44.8B)
GYRE THERAPEUTICS, INC.
Shares:68
Value:$525
% of Portfolio:0.0% ($525/$44.8B)
Solid Biosciences Inc.
Shares:141
Value:$522
% of Portfolio:0.0% ($522/$44.8B)
Ispire Technology Inc.
Shares:190
Value:$519
% of Portfolio:0.0% ($519/$44.8B)
Tuya Inc.
Shares:162
Value:$491
% of Portfolio:0.0% ($491/$44.8B)
Inozyme Pharma, Inc.
Shares:539
Value:$490
% of Portfolio:0.0% ($490/$44.8B)
Pyxis Oncology, Inc.
Shares:490
Value:$480
% of Portfolio:0.0% ($480/$44.8B)
Jasper Therapeutics, Inc.
Shares:111
Value:$477
% of Portfolio:0.0% ($477/$44.8B)
CervoMed Inc.
Shares:52
Value:$476
% of Portfolio:0.0% ($476/$44.8B)
Noah Holdings Ltd
Shares:50
Value:$473
% of Portfolio:0.0% ($473/$44.8B)
TILLY'S, INC.
Shares:213
Value:$469
% of Portfolio:0.0% ($469/$44.8B)
TruBridge, Inc.
Shares:17
Value:$468
% of Portfolio:0.0% ($468/$44.8B)
Tenaya Therapeutics, Inc.
Shares:818
Value:$466
% of Portfolio:0.0% ($466/$44.8B)
Anteris Technologies Global Corp.
Shares:126
Value:$459
% of Portfolio:0.0% ($459/$44.8B)
Kyverna Therapeutics, Inc.
Shares:237
Value:$457
% of Portfolio:0.0% ($457/$44.8B)